Accenture saw a positive improvement to its Relative Strength (RS) Rating on Friday, with an increase from 67 to 72.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
IBD's proprietary rating identifies market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the last 52 weeks stacks up against all the other stocks in our database.
History shows that the market's biggest winners often have an RS Rating north of 80 in the early stages of their moves. See if Accenture can continue to show renewed price strength and clear that threshold.
See How IBD Helps You Make More Money In Stocks
While the stock is not near an ideal buy zone right now, see if it goes on to form and break out from a proper base. Recent action has caused the stock to be a little extended, having cleared key moving averages.
Accenture Stock showed -6% EPS growth last quarter. Revenue gains came in at 5%. Look for the next report on or around Jun. 22.
The company holds the No. 6 rank among its peers in the Computer-Technical Services industry group. CGI and N-able are also among the group's highest-rated stocks.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
